v3.26.1
Acquisitions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended 15 Months Ended
Jul. 01, 2025
Apr. 01, 2025
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2026
Total Consideration:                    
Total cash paid, net           $ 0 $ 143,328,862      
Assets acquired                    
Goodwill       $ 357,211,919 [1]   360,849,822   $ 360,849,822 $ 357,211,919 [1] $ 360,849,822
BioConnect                    
Total Consideration:                    
Cash paid $ 12,996,275             12,996,275    
Less: cash acquired (113,545)             (113,545)    
Total cash paid, net 12,882,730             12,882,730    
Assets acquired                    
Accounts receivable 1,836,809         1,836,809   1,836,809   1,836,809
Inventory 1,176,471         1,176,471   1,176,471   1,176,471
Prepaid expenses and other current assets 111,143         111,143   111,143   111,143
Property, plant, and equipment 63,866         63,866   63,866   63,866
Goodwill 3,399,491         3,829,234   3,829,234   3,829,234
Deferred tax asset 0         673,198   673,198   673,198
Total assets acquired, excluding cash 15,852,486         15,852,486   15,852,486   15,852,486
Liabilities assumed:                    
Accounts payable 603,234         603,234   603,234   603,234
Accrued expenses and other current liabilities 369,074         369,074   369,074   369,074
Other liabilities 1,997,448         1,997,448   1,997,448   1,997,448
Total liabilities assumed 2,969,756         2,969,756   2,969,756   2,969,756
Measurement Period Adjustments                    
Goodwill       $ 400,000       429,743    
Deferred tax asset               673,198    
Total assets acquired, excluding cash               0    
Net assets acquired, excluding cash               0    
Net assets acquired, excluding cash 12,882,730         12,882,730   12,882,730   12,882,730
BioConnect | Trade names and trademarks                    
Assets acquired                    
Intangible asset 882,353         882,353   882,353   882,353
BioConnect | Developed technology                    
Assets acquired                    
Intangible asset 6,617,647         5,514,706   5,514,706   5,514,706
Measurement Period Adjustments                    
Intangible assets               (1,102,941)    
BioConnect | Customer relationships                    
Assets acquired                    
Intangible asset $ 1,764,706         1,764,706   1,764,706   1,764,706
VOXX                    
Total Consideration:                    
Cash paid   $ 148,256,998                
Less: cash acquired   (9,077,136)                
Total cash paid, net   139,179,862                
Fair value of previously held investment in VOXX   48,478,560     $ 48,500,000          
Total transaction consideration, net   187,658,422                
Assets acquired                    
Accounts receivable   56,719,726       56,719,726   56,719,726   56,719,726
Inventory   96,718,000       96,718,000   96,718,000   96,718,000
Prepaid expenses and other current assets   20,294,973       20,431,540   20,431,540   20,431,540
Income tax recoverable   5,243,038       4,280,703   4,280,703   4,280,703
Property, plant, and equipment   44,977,000       44,977,000   44,977,000   44,977,000
Equity investment   19,000,000       19,000,000   19,000,000   19,000,000
Goodwill   0       16,478,978   16,478,978   16,478,978
Deferred tax asset   32,537,099       32,673,698   32,673,698   32,673,698
Operating lease, right of use assets   5,404,163       5,404,163   5,404,163   5,404,163
Other assets   3,445,075       3,445,075   3,445,075   3,445,075
Total assets acquired, excluding cash   284,339,074       300,128,883   300,128,883   300,128,883
Liabilities assumed:                    
Accounts payable   31,347,556       31,096,255   31,096,255   31,096,255
Accrued expenses and other current liabilities   51,772,746       67,436,043   67,436,043   67,436,043
Income taxes payable   684,033       1,061,846   1,061,846   1,061,846
Debt   3,909,290       3,909,290   3,909,290   3,909,290
Other tax liabilities   791,593       791,593   791,593   791,593
Operating lease liabilities   3,435,604       3,435,604   3,435,604   3,435,604
Other liabilities   1,260,830       1,260,830   1,260,830   1,260,830
Total liabilities assumed   93,201,652       108,991,461   108,991,461   108,991,461
Measurement Period Adjustments                    
Prepaid expenses and other current assets                   136,567
Income tax recoverable                   (962,335)
Goodwill     $ 16,500,000           $ 16,500,000 16,478,978
Deferred tax asset                   136,599
Total assets acquired, excluding cash                   15,789,809
Accounts payable                   (251,301)
Accrued expenses and other current liabilities                   15,663,297
Income taxes payable                   377,813
Total liabilities assumed                   15,789,809
Net assets acquired, excluding cash                   0
Redeemable and non-redeemable non-controlling interests in consolidated subsidiaries   3,479,000       3,479,000   3,479,000   3,479,000
Net assets acquired, excluding cash   $ 187,658,422       $ 187,658,422   $ 187,658,422   $ 187,658,422
[1] The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from the audited Consolidated Financial Statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.